Friday, July 10, 2020 9:32:11 AM
NOTICE OF ENTRY OF ORDER SCHEDULING HEARING ON SHORTENED NOTICE TO DETERMINE, AMONG OTHER RELIF, WHETHER THE PROPOSED DISCLOSURE STATEMENT FOR THE DEBTOR’S AND AUCTUS FUND, LLC’S JOINT PLAN OF REORGANIZATION, DATED JULY 8, 2020, SHOULD BE FOUND TO CONTAIN “ADEQUATE INFORMATION”
PLEASE TAKE NOTICE that on July 9, 2020, the United States Bankruptcy Court for the Eastern District of New York entered an Order Scheduling Hearing on Shortened Notice [ECF Doc. No. 76] in the above captioned case, a copy of which is attached, setting August 3, 2020, at
10:00 a.m. as the hearing date and time for the Court to consider that part of the Joint Motion for Order: (A) Approving Adequacy of Disclosure Statement for the Debtor’s and Auctus Fund, LLC’s Joint Plan of Reorganization; (B) Establishing Procedures for Solicitation and Tabulation of Votes to Accept or Reject the Plan; (C) Scheduling a Hearing on Confirmation of the Plan; (D) Shortening Time for the Hearing on Approval of the Disclosure Statement and Confirmation of the
Plan and (E) Approving Related Notice Procedures [ECF Doc. No. 74] (the “Motion”) as to whether the proposed Disclosure Statement contains “adequate information” and whether other plan process notice and deadlines should be shortened (collectively, the “Disclosure Statement
Relief”).
PLEASE TAKE FURTHER NOTICE, that the Hearing shall be held telephonically on August 3, 2020 at 10:00 a.m. (prevailing Eastern Time) before the Honorable Judge Robert E. Grossman, Courtroom 860, United States Bankruptcy Court for the Eastern District of New York (the “Bankruptcy Court”), 290 Federal Plaza, Central Islip, New York 11722. The telephonic
hearing will be conducted using Court Solutions LLC. All attorneys and parties wishing to appear at, or attend, this telephonic hearing must make arrangements with Court Solutions no later than 12:00 p.m. on the business day prior to the hearing date. Instructions for registration with Court Solutions can be found on the Court’s website at https://www.nyeb.uscourts.gov/sites/nyeb/files/Court-solutions-registration-instructions.pdf.
PLEASE TAKE FURTHER NOTICE, that any written responses or objections to the Motion concerning the Disclosure Statement Relief shall: (a) be in writing; (b) state the name and address of the objecting party and the nature of the Claim or Interest of such party; (c) state with
particularity the basis and nature of any objection to confirmation of the Plan; and (d) be filed with the Court and a copy served on (i) Certilman Balin Adler & Hyman, LLP (Attention: Robert D. Nosek, Esq.), counsel the Debtor; (ii) Murphy & King, P.C., One Beacon Street, 21st Floor, Boston, MA 02108 (Attn: William R. Moorman, Jr., Esq.), counsel to Auctus Fund, LLC and (iii) Office of the United States Trustee, Alfonse D’Amato Courthouse, 560 Federal Plaza, Central Islip, New York 11722, (Attn: Stan Y. Yang, Esq.), so that such objections are received no later
than July 27, 2020 at 4:00 p.m.
PLEASE TAKE FURTHER NOTICE, that the Hearing may be adjourned from time to time without further notice other than the announcement of such adjournment in open Court, or the filing of a notice of adjournment on the docket of the Debtor’s case.
Dated: East Meadow, New York
July 9, 2020
CERTILMAN BALIN ADLER & HYMAN, LLP
Counsel to the Debtor and Debtor in Possession
By: _/s/ Robert D. Nosek ___
RICHARD J. MCCORD, ESQ
Robert D. Nosek, Esq.
90 Merrick Avenue
East Meadow, New York 11554
(516) 296-7000
Recent BRTX News
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/03/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:33:16 PM
- BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs • GlobeNewswire Inc. • 09/19/2024 10:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:11:03 PM
- BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:47:26 PM
- BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM